WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato ... Breakthroughs, discoveries, and DIY tips sent every weekday.

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

Attach ornaments to a foam ball for a festive holiday decoration. Trump signs executive orders on border, citizenship, TikTok and more ‘The Last Showgirl’ review: Pamela Anderson gives Oscar ...

Combining the two — gardening and houseplants — offers a third option: terrariums — those perfectly contained indoor ecosystems as small as a bottle or as large as an old unused aquarium.

Danish investment firm Novo Holdings, which has invested in Manipal Hospitals and Qure.ai Technologies in India, has appointed a new head for its local operations as it looks to ramp up its activities ...

Macau’s Xingchun Wang is now the second-biggest shareholder in Star, although the embattled casino operator and its bankers are in the dark about who he is and what his intentions are.

The Business Backer is a trusted funding partner that seeks to help small businesses thrive. The Business Backer helps small businesses get the best type of financing for their unique situation.

Unfortunately, there’s no exact way to rank who spent the most. This is because rounds with multiple investors rarely come with a disclosed breakdown of each backer’s share. Nonetheless, we can get a ...